ALLUVI BPC157 & TB500 40MG

£159.00

A 40mg BPC-157 & TB-500 formulation supplied in a pre-filled research device, provided exclusively for controlled laboratory R&D applications. Delivered in sealed format to support compound stability analysis, formulation studies, and delivery mechanism evaluation. Produced for laboratory research only. Not for human or veterinary consumption.

Add to wishlistAdd to compare
SKU: ALBPCTB Category:

BPC-157

Laboratory and animal studies suggest BPC-157 may influence:

  • Blood-vessel formation and VEGF signalling
  • Fibroblast and endothelial-cell movement
  • Collagen deposition and wound remodelling
  • Nitric-oxide pathways and blood-vessel function
  • Inflammatory and oxidative-stress responses

TB-500

TB-500 has been chemically identified as Ac-LKKTETQ, a seven-amino-acid fragment associated with thymosin beta-4. Full-length thymosin beta-4 is involved in actin regulation, cell movement and tissue remodelling.

Studies involving thymosin beta-4 have reported effects on:

  • Cell migration
  • Formation of new blood vessels
  • Extracellular-matrix remodelling
  • Skin and corneal wound repair
  • Inflammatory signalling

The combination is promoted as a “recovery blend,” with BPC-157 supposedly supporting local repair and TB-500 supposedly supporting broader cell migration and tissue remodelling. There are no good controlled human trials demonstrating that combining them heals injuries faster or is safe.

Each BPC-157 & TB-500 40mg Research kit includes: Pre-filled Research pen (20mg BPC-157, 20mg TB-500) Research information sheet

Reviews

There are no reviews yet.

Be the first to review “ALLUVI BPC157 & TB500 40MG”

Your email address will not be published. Required fields are marked *

Start typing and press Enter to search

Shopping Cart

No products in the cart.